RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 Outcomes with Apixaban by Type of AF
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 6
SP 12
OP 12
DO 10.1177/155989771206008
UL http://mdc.sagepub.com/content/12/6/12.abstract
AB Atrial fibrillation (AF) guidelines recommend identical treatments for stroke prevention for all types of AF (permanent, persistent, paroxysmal), based on known risk factors for stroke. This article discusses the results of a secondary analysis of the Apixaban for the Prevention of Stroke in Subjects with Atrial Fibrillation [ARISTOTLE; NCT00412984] trial, comparing rates of stroke or systemic embolism, bleeding, and mortality by AF type and treatment group.